Target intelligence / Profile preview

Nerve membrane

Molecular classification
Other
01

Overview

The nerve membrane, also known as the neuronal plasma membrane or axolemma, is a specialized lipid bilayer that defines the boundary of the neuron and maintains the electrochemical gradients essential for nervous system function (NCBI, NBK26856). It serves as the structural scaffold for a diverse array of proteins, including voltage-gated ion channels, ligand-gated receptors, and active transporters, which together facilitate the generation and propagation of action potentials (Neuroscience, NBK10883). Pharmacologically, the nerve membrane is the primary site of action for local anesthetics like lidocaine, which partition into the membrane to block sodium channels and prevent pain signal transmission (StatPearls, NBK532905). Additionally, general anesthetics and certain alcohols are thought to interact with the membrane's lipid environment or its embedded proteins to alter neuronal excitability. Pathological conditions such as multiple sclerosis involve the degradation of the membrane's protective myelin sheath, while neurodegenerative diseases often involve membrane disruption or protein aggregation on the membrane surface (PubMed, 25233415). Because the term "nerve membrane" encompasses an entire cellular structure rather than a single molecular entity, it is typically categorized as a site of action rather than a discrete therapeutic target in modern drug development.

Other names
Neuronal membraneAxolemmaPlasma membrane of neuronsNeural membrane
02

Mechanism of action

Inhibition of voltage-gated sodium channels to block nerve impulse conduction and modulation of membrane fluidity or membrane-bound protein activity.

03

Biological functions

Signal transductionAction potential propagationIon homeostasisCellular compartmentalization
04

Disease associations

Neurodegenerative diseaseNeuropathic painDemyelinating disordersEpilepsy
05

Safety considerations

Local anesthetic systemic toxicity (LAST)NeurotoxicityNerve injuryCardiotoxicity
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Neurofilament light chain (NfL)Myelin basic protein (MBP)

Beyond the preview

Go deeper on Nerve membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerve membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call